This nonopioid veterinary tranquilizer, which is not approved for human use, is linked to an alarming number of drug overdose deaths across the United States.
Multidisciplinary collaboration coupled with the use of multimodal strategies has enabled the tailoring of treatment plans based on the patient’s medical status and type of surgery.
Newer drugs are more targeted than standard agents, but their incorporation into treatment regimens is challenging because of the risk of cardiovascular and infectious adverse events.